Published in Semin Perinatol on December 01, 2004
Intrathecal Stem Cells for Cerebral Palsy Phase II (ISCII) | NCT02231242
Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem (2006) 1.36
Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol (2009) 1.36
Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci (2006) 1.29
Excitotoxic damage to white matter. J Anat (2007) 1.19
Glutamate and ATP signalling in white matter pathology. J Anat (2011) 1.11
Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci (2007) 1.11
Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol (2007) 1.08
Progenitor cell-based treatment of the pediatric myelin disorders. Arch Neurol (2011) 1.03
Executive dysfunction in poor readers born prematurely at high risk. Dev Neuropsychol (2009) 0.99
Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J Physiol (2008) 0.98
The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease. Front Psychiatry (2012) 0.97
Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics (2009) 0.95
GFP imaging of live astrocytes: regional differences in the effects of ischaemia upon astrocytes. J Anat (2007) 0.95
Inflammation in adult and neonatal stroke. Clin Neurosci Res (2006) 0.94
Mechanisms of perinatal arterial ischemic stroke. J Cereb Blood Flow Metab (2014) 0.93
Noninvasive cerebral perfusion imaging in high-risk neonates. Semin Perinatol (2010) 0.93
Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem (2008) 0.92
Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia. Neuroscience (2009) 0.89
Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection. Pediatr Res (2011) 0.89
Effects of treadmill exercise-intensity on short-term memory in the rats born of the lipopolysaccharide-exposed maternal rats. J Exerc Rehabil (2015) 0.88
Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci (2013) 0.87
Sex-specific cognitive deficits and regional brain volume loss in mice exposed to chronic, sublethal hypoxia. Pediatr Res (2011) 0.86
Maternal infection and white matter toxicity. Neurotoxicology (2006) 0.86
Roles of white matter in central nervous system pathophysiologies. ASN Neuro (2012) 0.83
Central axons preparing to myelinate are highly sensitive [corrected] to ischemic injury. Ann Neurol (2012) 0.82
How to make an oligodendrocyte. Development (2015) 0.81
Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am J Pathol (2009) 0.81
Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury. J Control Release (2015) 0.80
Increased prefrontal activation in adolescents born prematurely at high risk during a reading task. Brain Res (2009) 0.79
Novel morphological features of developing white matter pericytes and rapid scavenging of reactive oxygen species in the neighbouring endothelia. J Anat (2011) 0.78
White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors. Brain Sci (2013) 0.77
Diazoxide promotes oligodendrocyte differentiation in neonatal brain in normoxia and chronic sublethal hypoxia. Brain Res (2014) 0.77
Diffusion-weighted imaging of the brain in infants and children. Pediatr Radiol (2007) 0.76
Prenatal ischemia deteriorates white matter, brain organization, and function: implications for prematurity and cerebral palsy. Dev Med Child Neurol (2016) 0.76
The pathophysiology of ischemic injury to developing white matter. Mcgill J Med (2006) 0.76
Scoring system for periventricular leukomalacia in infants with congenital heart disease. Pediatr Res (2015) 0.75
CHRONIC NEONATAL DIAZOXIDE THERAPY IS NOT ASSOCIATED WITH ADVERSE EFFECTS. Online J Biol Sci (2014) 0.75
How fast is too fast? a practice change in umbilical arterial catheter blood sampling using the Iowa Model for Evidence-Based Practice. Adv Neonatal Care (2008) 0.75
Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies. Front Neurosci (2017) 0.75
Microglia-derived IL-1β contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats. J Neuroinflammation (2017) 0.75
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract (2011) 3.40
It is (sort of) a boy and (sort of) a girl. You have (sort of) a say and you (sort of) don't? The uneasiness of genital restoration surgery. J Pediatr Endocrinol Metab (2006) 2.67
I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer. J Clin Endocrinol Metab (2011) 2.02
Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci U S A (2002) 1.81
Putting propylthiouracil in perspective. J Clin Endocrinol Metab (2009) 1.73
American pediatric academia: the looming question. J Pediatr (2007) 1.66
Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol (2006) 1.44
Ending propylthiouracil-induced liver failure in children. N Engl J Med (2009) 1.40
A1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proc Natl Acad Sci U S A (2003) 1.18
Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem (2002) 1.09
Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res (2002) 1.04
A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc Natl Acad Sci U S A (2007) 1.02
Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol (2002) 1.01
Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn (2003) 1.00
Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. Dev Biol (2006) 0.98
Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol (2008) 0.98
Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid (2013) 0.97
Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation. Am J Physiol Endocrinol Metab (2005) 0.95
Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport (2006) 0.94
Hypoxia alters cell cycle regulatory protein expression and induces premature maturation of oligodendrocyte precursor cells. PLoS One (2009) 0.93
Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab (2003) 0.92
Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action. Biochem J (2004) 0.92
Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J (2008) 0.90
Cytoskeletal protein 4.1G is a binding partner of the metabotropic glutamate receptor subtype 1 alpha. J Neurosci Res (2004) 0.90
Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination. PLoS One (2010) 0.89
Putative tumor suppressor protein 4.1B is differentially expressed in kidney and brain via alternative promoters and 5' alternative splicing. Biochim Biophys Acta (2004) 0.88
Anaphylactic reaction to recombinant insulin-like growth factor-I. J Pediatr Endocrinol Metab (2008) 0.88
Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos. Birth Defects Res A Clin Mol Teratol (2008) 0.86
Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. Glia (2003) 0.86
Lost lessons of glucocorticoid potency and the treatment of children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab (2008) 0.86
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86
Rho-associated kinases play a role in endocardial cell differentiation and migration. Dev Biol (2004) 0.86
The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development. BMC Dev Biol (2011) 0.85
Identification of the heart as the critical site of adenosine mediated embryo protection. BMC Dev Biol (2010) 0.84
Intracellular calcium plays an essential role in cardiac development. Dev Dyn (2003) 0.83
A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport (2002) 0.83
Myopathy Associated with Acute Hypothyroidism following Radioiodine Therapy for Graves Disease in an Adolescent. Int J Pediatr Endocrinol (2010) 0.83
Detection of Turner syndrome using high-throughput quantitative genotyping. J Clin Endocrinol Metab (2005) 0.82
A "locked-on," constitutively active mutant of the adenosine A1 receptor. Eur J Pharmacol (2005) 0.82
Treatment of pediatric Graves' disease is associated with excessive weight gain. J Clin Endocrinol Metab (2011) 0.81
Resistance to thyroid hormone associated with a novel mutation of the thyroid β receptor gene in a four-year-old female. Int J Pediatr Endocrinol (2011) 0.81
Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos. FASEB J (2012) 0.80
Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function. PLoS One (2011) 0.79
Propylthiouracil is teratogenic in murine embryos. PLoS One (2012) 0.79
Lysophosphatidic acid regulates the proliferation and migration of olfactory ensheathing cells in vitro. Glia (2003) 0.79
Effect of patient Age on surgical outcomes for Graves' disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center. Int J Pediatr Endocrinol (2013) 0.78
Incidence of vitiligo in children with Graves' disease and Hashimoto's thyroiditis. Int J Pediatr Endocrinol (2011) 0.78
McCune-Albright syndrome: 70 years of fascination and discovery. J Pediatr Endocrinol Metab (2007) 0.78
Off-label use of recombinant igf-I to promote growth: is it appropriate? J Clin Endocrinol Metab (2010) 0.78
Prenatal virilization associated with paternal testosterone gel therapy. Int J Pediatr Endocrinol (2010) 0.77
Graves' disease therapy in children: truth and inevitable consequences. J Pediatr Endocrinol Metab (2007) 0.77
Advertised calories per hour...2000+: anti-obesity announcements per hour...0. J Pediatr Endocrinol Metab (2007) 0.77
Why the consensus for consensus? J Pediatr Endocrinol Metab (2008) 0.76
No trans fat for you! New York City's bold step. J Pediatr Endocrinol Metab (2007) 0.76
The early seeds of obesity: are childhood obesity programs too late to the table? J Pediatr Endocrinol Metab (2008) 0.75
Molecular diagnostic testing for Klinefelter syndrome and other male sex chromosome aneuploidies. Int J Pediatr Endocrinol (2012) 0.75
The evolving field of 'onco-endocrinology'. J Pediatr Endocrinol Metab (2008) 0.75
Evaluation of developmental toxicity of propylthiouracil and methimazole. Birth Defects Res B Dev Reprod Toxicol (2014) 0.75
Time to wake-up to the individual variation in sleep needs. J Clin Endocrinol Metab (2003) 0.75
Fat and the beanstalk. J Pediatr Endocrinol Metab (2008) 0.75
The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate. J Pediatr Endocrinol Metab (2008) 0.75
Continued catch-up growth in neonatal endocrinology. J Pediatr Endocrinol Metab (2007) 0.75
Performance enhancing endocrinology: the arbitrary line of acceptability. J Pediatr Endocrinol Metab (2008) 0.75
This is not your mentors' NIH--new strategies for research support. J Pediatr Endocrinol Metab (2006) 0.75
"The Newborn Screening Saves Lives Act"--four million calls for support! J Pediatr Endocrinol Metab (2007) 0.75
Should off-label drug use be off-the-table? J Pediatr Endocrinol Metab (2007) 0.75
No child need have unrecognized diabetes mellitus. J Pediatr Endocrinol Metab (2007) 0.75
Turning negatives to positives--moving mudslinging to child health betterment. J Pediatr Endocrinol Metab (2006) 0.75
Health care coverage in America: the penalty of the uninsured, insured and physician. J Pediatr Endocrinol Metab (2007) 0.75
Medical Moneyball: a model for academic pediatric growth. J Pediatr Endocrinol Metab (2008) 0.75